T1	intervention 0 20	Sentinel node biopsy
T2	eligibility 76 132	early breast cancer with clinically negative lymph nodes
T4	control-participants 843 866	One hundred and fifteen
T6	intervention-participants 910 913	110
T7	outcome 933 945	positive SLN
T8	cv-bin-abs 959 961	27
T9	iv-bin-abs 994 996	31
T12	outcome 1168 1187	axillary recurrence
T11	outcome 1050 1061	Sensitivity
T14	outcome 1066 1092	negative predictive values
T10	outcome 1014 1030	Overall accuracy
T15	iv-bin-percent 1043 1048	93.0%
T16	iv-bin-percent 1098 1103	77.1%
T17	iv-bin-percent 1108 1113	91.1%
T18	iv-bin-abs 1165 1167	no
T19	control 35 63	complete axillary dissection
T5	outcome 1218 1220	OS
T13	outcome 1225 1244	event-free survival
T3	outcome-Measure 796 817	overall survival (OS)
T20	outcome-Measure 822 841	axillary recurrence
